Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 7 January 2014
[DOI: 10.1126/scisignal.2004207]

Supplementary Materials for:

TRAF6 Stimulates the Tumor-Promoting Effects of TGFβ Type I Receptor Through Polyubiquitination and Activation of Presenilin 1

Shyam Kumar Gudey, Reshma Sundar, Yabing Mu, Anders Wallenius, Guangxiang Zang, Anders Bergh, Carl-Henrik Heldin, Marene Landström*

*Corresponding author. E-mail: marene.landstrom{at}medbio.umu.se

This PDF file includes:

  • Fig. S1. TGFβ promotes endoproteolytic cleavage of PS1.
  • Fig. S2. Schematic overview of the PLA.
  • Fig. S3. TGFβ promotes Lys63-dependent polyubiquitination of PS1 in cells.
  • Fig. S4. Identification of the PS1 cleavage site in TβRI.
  • Fig. S5. TGFβ promotes the colocalization of ectopically expressed TβRI and PS1, and treatment with monensin prevents activation of the γ-secretase complex and nuclear translocation of TβRI-ICD.
  • Fig. S6. TGFβ-induced invasive behavior of TRAMPC2 cells in vitro.
  • Fig. S7. Effects of a γ-secretase inhibitor on a xenograft prostate cancer model in vivo.
  • Fig. S8. Proposed simplified model of TGFβ-induced and TRAF6-dependent generation of TβRI-ICD.

[Download PDF]

Technical Details

Format: Adobe Acrobat PDF

Size: 4.63 MB


Citation: S. K. Gudey, R. Sundar, Y. Mu, A. Wallenius, G. Zang, A. Bergh, C.-H. Heldin, M. Landström, TRAF6 Stimulates the Tumor-Promoting Effects of TGFβ Type I Receptor Through Polyubiquitination and Activation of Presenilin 1. Sci. Signal. 7, ra2 (2014).

© 2014 American Association for the Advancement of Science


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882